Immunotherapy Vaccine and Herceptin in Breast Cancer

NCT03014076 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Breastcancer

Interventions

DRUG: GP2 peptide + GM-CSF vaccine plus trastuzumab
DRUG: Trastuzumab

Sponsor

Cancer Insight, LLC